AXA S.A. – Alnylam Pharmaceuticals, Inc. Transaction History
AXA S.A. portfolio value:
$37.59M
portfolio value
AXA S.A. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.35% | -10.61K shares | 8.65M | $200.16 | 187.84K |
| Q2 2022 | share | Decrease | -4.54% | -9.43K shares | -5.00M | $145.85 | 198.45K |
| Q1 2022 | share | Decrease | -2.72% | -5.80K shares | -2.29M | $163.29 | 207.89K |
| Q4 2021 | share | Increase | +32.38% | 52.27K shares | 5.76M | $171.03 | 213.70K |
| Q3 2021 | share | Increase | +35.65% | 42.42K shares | 10.30M | $188.81 | 161.43K |
| Q2 2021 | share | Decrease | -24.90% | -39.46K shares | -2.20M | $169.52 | 119.00K |
| Q1 2021 | share | Increase | +14.87% | 20.51K shares | 4.44M | $141.19 | 158.47K |
| Q4 2020 | share | Increase | +6.76% | 8.74K shares | -883K | $129.97 | 137.95K |
| Q3 2020 | share | Increase | +3.41% | 4.25K shares | 306K | $145.6 | 129.21K |
| Q2 2020 | share | Increase | +4.44% | 5.31K shares | 5.48M | $148.11 | 124.96K |
| Q1 2020 | share | Decrease | -11.90% | -16.16K shares | -2.61M | $108.85 | 119.64K |
| Q4 2019 | share | Decrease | -18.38% | -30.58K shares | 2.25M | $115.17 | 135.81K |
| Q3 2019 | share | Decrease | -0.22% | -363 shares | 1.28M | $80.42 | 166.40K |
| Q2 2019 | share | Increase | +1.92% | 3.13K shares | -3.19M | $72.56 | 166.76K |
| Q1 2019 | share | Decrease | -0.17% | -271 shares | 3.34M | $93.45 | 163.62K |
| Q4 2018 | share | Increase | +121.25% | 89.82K shares | 5.46M | $72.91 | 163.9K |
| Q3 2018 | share | Increase | 0.00% | 74.07K shares | 6.48M | $87.52 | 74.07K |
| Q2 2018 | share | Decrease | -100.00% | -1.88K shares | -225K | $98.49 | 0 |
| Q1 2018 | share | Increase | 0.00% | 1.88K shares | 225K | $119.1 | 1.88K |
| Q4 2017 | share | Decrease | -100.00% | -40.31K shares | -4.73M | $127.05 | 0 |
| Q3 2017 | share | Decrease | -71.45% | -100.89K shares | -6.52M | $117.49 | 40.31K |
| Q2 2017 | share | Decrease | -42.19% | -103.07K shares | -1.25M | $79.76 | 141.21K |
| Q1 2017 | share | Increase | +90.60% | 116.12K shares | 7.72M | $51.25 | 244.28K |
| Q4 2016 | share | Increase | +1.93% | 2.42K shares | -3.72M | $37.44 | 128.16K |
| Q3 2016 | share | Increase | +0.06% | 72 shares | 1.54M | $67.78 | 125.73K |
| Q2 2016 | share | Increase | +27.33% | 26.97K shares | 778K | $55.49 | 125.66K |
| Q1 2016 | share | Increase | +50.50% | 33.11K shares | 22K | $62.77 | 98.68K |